Show simple item record

dc.contributor.authorThiele, Stefanie
dc.contributor.authorMungalpara, Jignesh
dc.contributor.authorSteen, A.
dc.contributor.authorRosenkilde, Mette M.
dc.contributor.authorVåbenø, Jon
dc.date.accessioned2015-03-05T11:04:54Z
dc.date.available2015-03-05T11:04:54Z
dc.date.issued2014
dc.identifier.citationBritish Journal of Pharmacology 171(2014) nr. 23 s. 5313-5329en_US
dc.identifier.cristinIDFRIDAID 1187718
dc.identifier.doi10.1111/bph.12842
dc.identifier.issn0007-1188
dc.identifier.urihttps://hdl.handle.net/10037/7344
dc.identifier.urnURN:NBN:no-uit_munin_6915
dc.language.isoengen_US
dc.publisherMacmillan Press Ltd.en_US
dc.rights.accessRightsopenAccess
dc.subjectVDP::Medisinske Fag: 700::Basale medisinske, odontologiske og veterinærmedisinske fag: 710::Farmakologi: 728en_US
dc.subjectVDP::Medical disciplines: 700::Basic medical, dental and veterinary science disciplines: 710::Pharmacology: 728en_US
dc.titleDetermination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesisen_US
dc.typeJournal articleen_US
dc.typeTidsskriftartikkelen_US
dc.typePeer revieweden_US


File(s) in this item

Thumbnail
Thumbnail

This item appears in the following collection(s)

Show simple item record